Aleksey V. Krat

Aleksey V. Krat

Auto-generated profile, based on publicly available information

Aleksey V. Krat

Professor V.F. Voino-Yasenetsky Krasnoyarsk State Medical University

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 December 2023 in Russian Journal of Oncology
Verified
Journal Article
Open access
PDF file
RZRuslan A. Zukov
Ruslan A. Zukov
ISIvan P. Safontsev
Ivan P. Safontsev
MKMarina P. Klimenok
Marina P. Klimenok
TZTatyana E. Zabrodskaya
Tatyana E. Zabrodskaya
AKAleksey V. Krat
Aleksey V. Krat
ЗНЗамай Татьяна Николаевна
Замай Татьяна Николаевна
BACKGROUND: Lung cancer occupies a leading position in the overall structure of cancer incidence in the Krasnoyarsk Territory. Despite the positive results of the introduction of low-dose computed tomography and the current epidemiological situation caused by the new coronavirus infection COVID-19, there remains the potential to increase the detection and implementation of modern methods for the diagnosis of lung cancer. AIM: The aim of the study was to study the incidence of lung cancer in the Krasnoyarsk Territory over the past 2012–2021 years, to build a forecast until 2030 and to search for leads in the diagnosis of this disease. MATERIALS AND METHODS: The data of the regional cancer register and the data of the Territorial Body of the Federal State Statistics Service for the Krasnoyarsk Territory were used as a source of information. We calculated the intensive indicator of lung cancer incidence in the territory of the region and predicted the incidence until 2030, using Microsoft Excel. RESULTS: Thus, the incidence of lung cancer in the Krasnoyarsk Territory increased by 4.6%, while the female incidence increased by 31.6% and the male incidence decreased by 2.7%. Incidence rates in the region exceed those typical for the city of Krasnoyarsk for the entire period of observation. The increase in incidence in the region for the period 2012–2021 was 4.3%, and in the city — 3.1%. The male population of the region, unlike Krasnoyarsk, is characterized by a slight increase in incidence. Female morbidity increased both in the region and in the city by 23.9% and 43.3%, respectively, during the observation period. The incidence of lung cancer in the region by 2030 may amount to 54.9 per 100 thousand population and in Krasnoyarsk — 41.0 per 100 thousand population. The absence of COVID-19 would provide a higher accuracy of the forecast — 66.9 and 43.8 per 100 thousand population, respectively. CONCLUSION: Thus, over the past 10 years, an increase in lung cancer cases has been registered in the Krasnoyarsk Territory. The article provides examples of modern methods of screening and diagnosis of lung cancer, including the use of aptamers. The presented data indicates the need to improve approaches in detecting lung cancer and monitoring the effectiveness of antitumor therapy using innovative approaches.

25 December 2024 in Russian Journal of Oncology
Verified
Journal Article
Closed access
PDF file
AKAleksey V. Krat
Aleksey V. Krat
DKDaria A. Kirichenko
Daria A. Kirichenko
GZGalina S. Zamay
Galina S. Zamay
RZRuslan A. Zukov
Ruslan A. Zukov
OKOlga S. Kolovskaya
Olga S. Kolovskaya
ПСПац Юрий Степанович
Пац Юрий Степанович
BACKGROUND: Lung cancer (LC) is one of the most prevalent types of cancer, with mortality rates reaching 25% of all cancer-related deaths. The majority of patients are classified as stage IV at the time of diagnosis, a stage at which the probability of successful treatment is considerably low. Conventional diagnostic methods for lung cancer are expensive, labor-intensive, and highly invasive if a biopsy is performed. Consequently, liquid biopsy, which involves the extraction of circulating tumor cells from blood samples, has emerged as a pivotal area of research in oncology. AIM: To develop a method for the isolation and identification of circulating tumor cells in the peripheral blood of patients with lung cancer using DNA aptamers. MATERIALS AND METHODS: The study objects are lung cancer tissue, blood of patients with lung cancer and primary lung cancer cell culture. Gold-decorated magnetic nanoparticles and thiolated aptamers LC-17, LC-183 and LC-224 were used to isolate proteins. A hybrid of a thiol primer and a non-specific DNA sequence composed of two AG nucleotide repeats was used as a control. Mass spectrometry was performed using UltiMate 3000 nano-UHPLC system coupled with Orbitrap Fusion mass spectrometer (Thermo Scientific, USA). Circulating tumor cell counts were measured on CytoFLEX flow cytometer (Beckman Coulter, USA) after triple staining. Fluorescence microscopy was used for CSC visualization. RESULTS: The potential protein targets of the aptamers LC-17, LC-183, and LC-224 were identified. These aptamers were then used to isolate circulating tumor cells from the blood of patients with lung cancer. The identification of circulating tumor cells was performed using flow cytometry and fluorescence microscopy. CONCLUSIONS: The proposed method for the identification of circulating tumor cells through magnetic separation and flow cytometry provides a quantitative analysis of the target analyte, facilitated by the use of cell-specific lung cancer aptamers, including LC-17, LC-183, and LC-224, which exhibit high-affinity binding properties.

20 December 2024 in Russian Journal of Oncology
Verified
Journal Article
Open access
PDF file
GZGalina S. Zamay
Galina S. Zamay
TZTatiana N. Zamay
Tatiana N. Zamay
DCDaniil S. Chumakov
Daniil S. Chumakov
SSSemen A. Sidorov
Semen A. Sidorov
AKAleksey V. Krat
Aleksey V. Krat
ХГХлебцов Николай Григорьевич
Хлебцов Николай Григорьевич
Background: The problem of recurrence, generalization, or metastasis of lung cancer remains relevant to this day, despite the advances in diagnostic and therapeutic methods of treatment. The main method of localized lung cancer treatment is surgery. The volume of resection is determined by the location of the tumor, its spread to surrounding tissues and the status of lymph node damage. However, even after removal of a large part of the lung, metastatic foci may remain in healthy tissue. To improve the effectiveness of diagnostics during surgery, fluorescence-navigated surgery can be used, based on the use of fluorescent dyes, which enables to see even small clusters of malignant cells in the early stages of tumor process development. Aim: To develop a drug for fluorescence-navigation surgery based on aptamers and fluorescent gold nanoclusters (fluorescence excitation wavelengths are 365–410 nm, emission wavelengths are 615–650 nm). Materials and Methods: The object of the study is primary cultures of non-small cell lung cancer. Liposomes functionalized with DNA aptamer LC-17 were used to deliver gold nanoclusters stabilized with glutathione (GSH-AuNC) or bovine serum albumin (BSA-AuNC) to lung cancer cells. Electron microscopic images of the synthesized nanoclusters were obtained using transmission electron microscopy. Analysis of the efficiency of tumor cell binding to aptamer-functionalized liposomes containing nanoclusters was performed using flow cytometry Lung adenocarcinoma tissue was used to evaluate the efficiency of fluorescent nanoclusters. Results: The diameter of BSA-AuNC and GSH-AuNC nanoclusters was 1.8±0.5 nm and 1.5±0.3 nm, respectively. When exciting by light with a wavelength of 365 nm, the maximum fluorescence emission for BSA-AuNCs was 655 nm, and for GSH-AuNCs — 613 nm. The fluorescence quantum yields for BSA-AuNCs and GSH-AuNCs were 6% and 14%, respectively. LC-17 aptamer-functionalized liposomes with included GSH-AuNC and BSA-AuNC effectively bound to lung adenocarcinoma cells and stained them. Conclusion: The possibilityl of using gold nanoclusters stabilized by GSH-AuNC and BSA-AuNC for fluorescence-guided surgery is demonstrated.